Brief: Panacea Biotec Says Unit Received USFDA Indicating Inspection Classification As "Official Action Indicated"
08/09/2022 09:37
Sept 8 (Reuters) - Panacea Biotec Ltd PNCA.NS :
* UNIT RECEIVED USFDA INDICATING INSPECTION CLASSIFICATION
AS
"OFFICIAL ACTION INDICATED"
* USFDA EXPECTS CORRECTIVE ACTIONS
* USFDA MAY WITHHOLD APPROVAL OF PENDING PRODUCT
APPLICATIONS,
SUPPLEMENTS FILED FROM FACILITY TILL OUTSTANDING OBSERVATIONS
ARE RESOLVED
Source text for Eikon: ID:nBSE2WYWst
Further company coverage: PNCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility